Skip to main content

May/June 2010, Vol 3, No 3

Original Research

Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations

Jeff Jianfei Guo, BPharm, PhD, Nick C. Patel, PharmD, PhD, Hong Li, PhD, Paul E. Keck Jr., MD

Stakeholder Perspective

Bipolar Disorder Prevalence Often Underestimated

by Nirav R. Shah, MD,MPH

Practice Management

Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

The Many Challenges of Pay-for-Performance Programs

by Gary M. Owens, MD

Practice Management

Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey

Denise Globe, PhD, Peter Mazonson, MD, MBA, Chris Santas, MBA, Regina Murphy, MBA, Annie Cheng, Xingyue Huang, PhD, Arthur Kavanaugh, MD

Stakeholder Perspective

What Is the Value of Specialty Pharmaceuticals?

Page 2 of 2
Results 11 - 13 of 13